NeueHealth, Inc. (NEUE)
(Delayed Data from NYSE)
$5.01 USD
+0.11 (2.14%)
Updated Aug 27, 2024 01:13 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for NeueHealth, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -1,265.81 | -1,359.88 | -1,184.86 | -248.44 | 125.34 |
Depreciation/Amortization & Depletion | 593.72 | 175.28 | 35.48 | 8.29 | 1.13 |
Net Change from Assets/Liabilities | -2,157.33 | 1,159.99 | 1,248.65 | 174.80 | 115.46 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 102.88 | 259.08 | -17.21 | 8.12 | 0.53 |
Net Cash From Operating Activities | -2,726.55 | 234.47 | 82.06 | -57.24 | -8.21 |
Property & Equipment | -2.90 | -27.45 | -30.41 | -6.47 | -0.79 |
Acquisition/ Disposition of Subsidiaries | -0.68 | -0.31 | -431.79 | -230.33 | -31.86 |
Investments | 1,123.21 | -401.97 | -90.69 | -452.94 | -62.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 1,119.63 | -429.72 | -552.89 | -689.74 | -94.64 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 921.73 | 11.39 | 712.44 | 424.06 |
Issuance (Repayment) of Debt | 66.40 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 148.95 | 155.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -16.49 | -4.31 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 877.25 | 0.00 | 0.00 |
Net Cash from Financing Activities | 49.91 | 1,066.37 | 1,043.64 | 712.44 | 424.06 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1,557.01 | 871.11 | 572.81 | -34.54 | 321.21 |
Cash at Beginning of Period | 1,932.29 | 1,061.18 | 488.37 | 522.91 | 201.70 |
Cash at End of Period | 375.28 | 1,932.29 | 1,061.18 | 488.37 | 522.91 |
Diluted Net EPS | -150.94 | -190.40 | -241.60 | -145.60 | NA |
Fiscal Year End for NeueHealth, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.88 | -4.18 | -1,265.81 | -805.24 | -258.09 |
Depreciation/Amortization & Depletion | 19.95 | 4.56 | 593.72 | 421.53 | 16.03 |
Net Change from Assets/Liabilities | -51.35 | -35.56 | -2,157.33 | -2,069.91 | -521.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.13 | -13.54 | 102.88 | 58.29 | 39.69 |
Net Cash From Operating Activities | -77.15 | -48.72 | -2,726.55 | -2,395.32 | -724.03 |
Property & Equipment | -0.88 | -0.06 | -2.90 | -2.63 | -2.39 |
Acquisition/ Disposition of Subsidiaries | 197.12 | 196.13 | -0.68 | -0.68 | -0.68 |
Investments | -6.96 | 2.32 | 1,123.21 | 1,148.75 | 160.20 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 189.28 | 198.39 | 1,119.63 | 1,145.44 | 157.13 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 52.41 | 0.00 | 66.40 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -273.64 | -273.64 | 0.00 | 50.00 | 0.00 |
Payment of Dividends & Other Distributions | -4.73 | -1.88 | -16.49 | -9.00 | -4.95 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -225.96 | -275.52 | 49.91 | 41.01 | -4.95 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -113.82 | -125.85 | -1,557.01 | -1,208.87 | -571.85 |
Cash at Beginning of Period | 375.28 | 375.28 | 1,932.29 | 1,932.29 | 1,932.29 |
Cash at End of Period | 261.46 | 249.43 | 375.28 | 723.42 | 1,360.44 |
Diluted Net EPS | -8.65 | -3.53 | -30.21 | -81.03 | -15.70 |